Press Releases

Date	Title	Company
23-Mar-2023	PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million	PureTech Health
23-Mar-2023	Axing the ‘gold standard’ weekly Covid Infection Survey shows blinkered complacency, says expert	London Medical Laboratory
23-Mar-2023	Hebrew University Researchers Identify How Pancreatic Cancer Cells Metastasize and Become Fatal	Hebrew University
23-Mar-2023	Fraud in the NHS – The hidden risks to your organisation	Netcall
23-Mar-2023	jaam automation publishes expert whitepaper on the topic of Intelligent Automation in Healthcare	jaam automation
23-Mar-2023	Digital Health Academy adds new CPD-accredited module to bridge the engagement gap between health innovators and patients	Boehringer Ingelheim, ORHCA
23-Mar-2023	Emmes Acquires Essex Management	Emmes
23-Mar-2023	InvoX Pharma’s F-star announces licence agreement with Takeda for second novel next-generation immuno-oncology bispecific antibody	InvoX Pharma Limited
23-Mar-2023	Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO	Tiziana Life Sciences
23-Mar-2023	New research shows there are 2 nutrients proven to stop your brain shrinking by up to 70%	About FoodForTheBrain.org
23-Mar-2023	Envirotainer sees improvements in access to biopharmaceuticals across the globe	Envirotainer
23-Mar-2023	Aqilion to recieve 20.1 MSEK after conversion of outstanding warrants	Aqilion
23-Mar-2023	Sequana Medical announces additional patents for DSR® in China and the United States	Sequana Medical
23-Mar-2023	APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region	EVERSANA
23-Mar-2023	Scientists warn of rise in potentially fatal bacterial infection due to global warming	The University of East Anglia
23-Mar-2023	Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancer	Macomics Ltd
23-Mar-2023	Original-Research: Haemato AG (von First Berlin Equity Research GmbH)	Haemato AG
23-Mar-2023	MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6)	MorphoSys AG
23-Mar-2023	Connect in Pharma releases report on future trends in pharma production and manufacturing	Sciad Newswire
23-Mar-2023	Cosmo reports record 2022 financial results exceeding guidance, increased dividend by 10%, confirms 2023 guidance	Cosmo Pharmaceuticals N.V.